Les telomeres et le vieillissement des cellules

Translated title of the contribution: Telomere-controlled senescence

Michel M Ouellette, Isabelle Savre-Train

Research output: Contribution to journalShort survey

11 Citations (Scopus)

Abstract

Most normal human cells have a finite life span. After a limited number of cell divisions, they reach a quiescent state termed senescence. During this process, cell cycle progression is blocked by the activation of p53 and the induction of p16(INK4a). The onset of senescence is controlled by the shortening of telomeres that occurs each time normal human cells divide. The observation that telomeres shortening occurs in vivo suggests that senescence may play a role in the aging process. The enzyme telomerase can extend the life span of human cells by synthesizing new telomeric DNA. This enzyme, absent from most somatic tissues, contains an RNA (hTR) that serves as a template for the synthesis of telomeric DNA and a reverse transcriptase (hTERT) that provides catalytic activity. The forced expression of exogenous hTERT in normal human cells is sufficient to reconstitute telomerase activity, maintain the size of telomere and prevent the induction of senescence. During carcinogenesis, senescence is frequently inhibited by the ectopic expression of telomerase. Although senescence might be detrimental as a potential cause of aging, its evolutionary advantage is to provide an additional obstacle to the development of cancers.

Original languageFrench
Pages (from-to)473-480
Number of pages8
JournalMedecine/Sciences
Volume16
Issue number4
StatePublished - Apr 1 2000

Fingerprint

Telomere
Cells
Telomerase
Telomere Shortening
Aging of materials
RNA-Directed DNA Polymerase
DNA
Enzymes
Cell Division
Catalyst activity
Cell Cycle
Carcinogenesis
Chemical activation
Tissue
Neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Les telomeres et le vieillissement des cellules. / Ouellette, Michel M; Savre-Train, Isabelle.

In: Medecine/Sciences, Vol. 16, No. 4, 01.04.2000, p. 473-480.

Research output: Contribution to journalShort survey

Ouellette, MM & Savre-Train, I 2000, 'Les telomeres et le vieillissement des cellules', Medecine/Sciences, vol. 16, no. 4, pp. 473-480.
Ouellette, Michel M ; Savre-Train, Isabelle. / Les telomeres et le vieillissement des cellules. In: Medecine/Sciences. 2000 ; Vol. 16, No. 4. pp. 473-480.
@article{58c58b10e0454124b5a362f8abd91fa1,
title = "Les telomeres et le vieillissement des cellules",
abstract = "Most normal human cells have a finite life span. After a limited number of cell divisions, they reach a quiescent state termed senescence. During this process, cell cycle progression is blocked by the activation of p53 and the induction of p16(INK4a). The onset of senescence is controlled by the shortening of telomeres that occurs each time normal human cells divide. The observation that telomeres shortening occurs in vivo suggests that senescence may play a role in the aging process. The enzyme telomerase can extend the life span of human cells by synthesizing new telomeric DNA. This enzyme, absent from most somatic tissues, contains an RNA (hTR) that serves as a template for the synthesis of telomeric DNA and a reverse transcriptase (hTERT) that provides catalytic activity. The forced expression of exogenous hTERT in normal human cells is sufficient to reconstitute telomerase activity, maintain the size of telomere and prevent the induction of senescence. During carcinogenesis, senescence is frequently inhibited by the ectopic expression of telomerase. Although senescence might be detrimental as a potential cause of aging, its evolutionary advantage is to provide an additional obstacle to the development of cancers.",
author = "Ouellette, {Michel M} and Isabelle Savre-Train",
year = "2000",
month = "4",
day = "1",
language = "French",
volume = "16",
pages = "473--480",
journal = "Medecine/Sciences",
issn = "0767-0974",
publisher = "Editions EDK",
number = "4",

}

TY - JOUR

T1 - Les telomeres et le vieillissement des cellules

AU - Ouellette, Michel M

AU - Savre-Train, Isabelle

PY - 2000/4/1

Y1 - 2000/4/1

N2 - Most normal human cells have a finite life span. After a limited number of cell divisions, they reach a quiescent state termed senescence. During this process, cell cycle progression is blocked by the activation of p53 and the induction of p16(INK4a). The onset of senescence is controlled by the shortening of telomeres that occurs each time normal human cells divide. The observation that telomeres shortening occurs in vivo suggests that senescence may play a role in the aging process. The enzyme telomerase can extend the life span of human cells by synthesizing new telomeric DNA. This enzyme, absent from most somatic tissues, contains an RNA (hTR) that serves as a template for the synthesis of telomeric DNA and a reverse transcriptase (hTERT) that provides catalytic activity. The forced expression of exogenous hTERT in normal human cells is sufficient to reconstitute telomerase activity, maintain the size of telomere and prevent the induction of senescence. During carcinogenesis, senescence is frequently inhibited by the ectopic expression of telomerase. Although senescence might be detrimental as a potential cause of aging, its evolutionary advantage is to provide an additional obstacle to the development of cancers.

AB - Most normal human cells have a finite life span. After a limited number of cell divisions, they reach a quiescent state termed senescence. During this process, cell cycle progression is blocked by the activation of p53 and the induction of p16(INK4a). The onset of senescence is controlled by the shortening of telomeres that occurs each time normal human cells divide. The observation that telomeres shortening occurs in vivo suggests that senescence may play a role in the aging process. The enzyme telomerase can extend the life span of human cells by synthesizing new telomeric DNA. This enzyme, absent from most somatic tissues, contains an RNA (hTR) that serves as a template for the synthesis of telomeric DNA and a reverse transcriptase (hTERT) that provides catalytic activity. The forced expression of exogenous hTERT in normal human cells is sufficient to reconstitute telomerase activity, maintain the size of telomere and prevent the induction of senescence. During carcinogenesis, senescence is frequently inhibited by the ectopic expression of telomerase. Although senescence might be detrimental as a potential cause of aging, its evolutionary advantage is to provide an additional obstacle to the development of cancers.

UR - http://www.scopus.com/inward/record.url?scp=0034107778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034107778&partnerID=8YFLogxK

M3 - Short survey

VL - 16

SP - 473

EP - 480

JO - Medecine/Sciences

JF - Medecine/Sciences

SN - 0767-0974

IS - 4

ER -